Michael W Gardner, Timur M Roytman, Cathy Chen, Steven B Brandes, Adam S Kibel, Robert L Grubb, Sam B Bhayani, Robert S Figenshau
BACKGROUND AND PURPOSE: At present, open retroperitoneal lymph node dissection (RPLND) remains the preferred approach at many high-volume centers for the surgical treatment of patients with low-stage testis cancer. Despite the potential advantages of a minimally invasive approach, including improved cosmesis and shorter recovery times, there remain concerns over the quality of dissection and oncologic control offered through a minimally invasive approach. Our objective was to critically evaluate the safety and intermediate-term oncologic efficacy of laparoscopic RPLND (L-RPLND)...
November 2011: Journal of Endourology